Rallybio is laying off nine employees, about 40% of its total headcount, as it reels from the loss of its lead asset, the biotech announced in its first-quarter earnings report May 8.
Rallybio is laying off nine employees, about 40% of its total headcount, as it reels from the loss of its lead asset, the biotech announced in its first-quarter earnings report May 8.